Novo Nordisk Frontier 4

News

Novo Nordisk ousts CEO

Novo Nordisk ousts CEO after falling behind in weight loss market

Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

Fox Business on MSN · 20h

Novo Nordisk CEO steps down as Wegovy maker faces increased competition

As Novo Nordisk's share price drops, CEO Lars Fruergaard Jorgensen steps down. The company aims to maintain its lead in the competitive weight-loss drug market.

NBC New York · 1d

Novo Nordisk ousts CEO as Wegovy maker faces growing competition

The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post “for a period to support a smooth transition to new leadership.”

18hon MSN

Novo Nordisk, U.S. biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

Zacks Investment Research on MSN1d

ETFs to Capitalize on the Novo Nordisk-Septerna Deal

Novo Nordisk NVO announced a significant partnership with Septerna SEPN, a U.S.-based biotech company, valued at up to $2.2 billion, to tap the growing obesity treatment market. Following the ...

Reuters23d

Novo Nordisk's stellar Wegovy-fuelled run of hiking sales guidance could be ending

LONDON, April 24 (Reuters) - Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk (NOVOb.CO ... drug for adrenal gland tumors 4:50 PM UTC · Updated ago U.S. energy ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Novo Nordisk ousts CEO

Trending now